BRIEF published on 04/30/2026 at 23:05, 4 months 11 days ago METAVISIO : Bilan 2025 et Perspectives pour 2026 Réduction De La Dette Redressement Judiciaire Résultats Financiers 2025 Perspectives 2026 Stratégie METAVISIO
BRIEF published on 04/30/2026 at 23:05, 4 months 11 days ago METAVISIO: 2025 Review and Outlook for 2026 Debt Reduction Judicial Reorganization 2025 Financial Results Outlook 2026 METAVISIO Strategy
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Curaleaf Finalizes Acquisition of Germany's Four 20 Pharma Acquisition European Market Medical Cannabis Curaleaf Holdings Four 20 Pharma
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Curaleaf finalise l'acquisition du groupe pharmaceutique allemand Four 20 Pharma. Acquisition Marché Européen Cannabis Médical Curaleaf Holdings Quatre 20 Pharma
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Mise à disposition du rapport financier annuel 2025 par HEXAOM Autorité Des Marchés Financiers Hexaom Commissaires Aux Comptes Rapport Financier 2025 Assemblée Générale 2026
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Qwamplify : Actualisation du capital et des droits de vote pour mars 2026 PEA-PME Capital Droits De Vote Euronext Growth Qwamplify
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago HEXAOM makes available its 2025 annual financial report Financial Markets Authority Auditors Hexaom Financial Report 2025 General Assembly 2026
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Qwamplify: Update of share capital and voting rights for March 2026 PEA-PME Voting Rights Capital Euronext Growth Qwamplify
BRIEF published on 04/30/2026 at 22:09, 4 months 11 days ago Interim Financial Statements Released by Sirma Group Holding Financial Statements Investor Relations Transparency Interim Report Sirma Group
BRIEF published on 04/30/2026 at 22:09, 4 months 11 days ago États financiers intermédiaires publiés par Sirma Group Holding Transparence États Financiers Relations Avec Les Investisseurs Rapport Intérimaire Groupe Sirma
Published on 09/12/2026 at 02:35, 41 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 4 hours 16 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 5 hours 11 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 5 hours 51 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 10 hours 16 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 5 hours 1 minute ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 5 hours 5 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 7 hours 31 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 9 hours ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 7 hours ago Availability of the 2026 Interim Financial Report
